Some studies reveal a role for DLL4 in tumorigenesis in several cancers, including T acute lymphoblastic leukemia (T-ALL) [46], and glioblastoma [47] etc. We found that overexpressing of DLL4 reverses malignant phenotypes inhibition of renal cancer cells induced by silencing UCA1. Here, DLL4 is linked to glioblastoma.